ATE186305T1 - Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung - Google Patents
Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellungInfo
- Publication number
- ATE186305T1 ATE186305T1 AT95917216T AT95917216T ATE186305T1 AT E186305 T1 ATE186305 T1 AT E186305T1 AT 95917216 T AT95917216 T AT 95917216T AT 95917216 T AT95917216 T AT 95917216T AT E186305 T1 ATE186305 T1 AT E186305T1
- Authority
- AT
- Austria
- Prior art keywords
- elastase
- inhibitors
- pct
- perfluoroalkyll
- ketones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25285794A | 1994-06-02 | 1994-06-02 | |
US32752094A | 1994-10-20 | 1994-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE186305T1 true ATE186305T1 (de) | 1999-11-15 |
Family
ID=26942742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95917216T ATE186305T1 (de) | 1994-06-02 | 1995-05-01 | Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung |
Country Status (19)
Country | Link |
---|---|
US (1) | US6008196A (de) |
EP (1) | EP0763055B1 (de) |
JP (1) | JP3721538B2 (de) |
KR (1) | KR100366328B1 (de) |
CN (1) | CN1152048C (de) |
AT (1) | ATE186305T1 (de) |
AU (1) | AU690986B2 (de) |
CA (1) | CA2189526C (de) |
DE (1) | DE69513167T2 (de) |
DK (1) | DK0763055T3 (de) |
ES (1) | ES2137509T3 (de) |
FI (1) | FI964789A0 (de) |
GR (1) | GR3032294T3 (de) |
HU (1) | HU221311B1 (de) |
IL (1) | IL113941A (de) |
NO (1) | NO316706B1 (de) |
NZ (1) | NZ284766A (de) |
TW (1) | TW376388B (de) |
WO (1) | WO1995033762A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
HU221310B1 (en) * | 1994-06-02 | 2002-09-28 | Merrell Pharma Inc | Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof |
JP3721538B2 (ja) * | 1994-06-02 | 2005-11-30 | メレル ファーマスーティカルズ インコーポレイテッド | エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法 |
US6159938A (en) * | 1994-11-21 | 2000-12-12 | Cortech, Inc. | Serine protease inhibitors comprising α-keto heterocycles |
US5998379A (en) * | 1994-11-21 | 1999-12-07 | Cortech Inc. | Serine protease inhibitors-proline analogs |
US20020119985A1 (en) | 1994-11-21 | 2002-08-29 | Albert Gyorkos | Serine protease inhibitors |
US6150334A (en) * | 1994-11-21 | 2000-11-21 | Cortech, Inc. | Serine protease inhibitors-tripeptoid analogs |
US6015791A (en) * | 1994-11-21 | 2000-01-18 | Cortech Inc. | Serine protease inhibitors-cycloheptane derivatives |
US6100238A (en) * | 1994-11-21 | 2000-08-08 | Cortech Inc. | Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors |
US6001811A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Serine protease inhibitors--N-substituted derivatives |
US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
US6001813A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Val-pro containing α-keto oxadiazoles as serine protease inhibitors |
US6001814A (en) * | 1994-11-21 | 1999-12-14 | Cortech Inc. | Serine protease inhibitors |
US6172044B1 (en) | 1995-12-01 | 2001-01-09 | Aventis Pharmaceuticals Inc. | Acylated enol derivative of α-ketoesters and α-ketoamides |
US5948886A (en) * | 1996-11-20 | 1999-09-07 | Hoechst Marion Roussel, Inc. | Acylated enol derivatives of α-ketoesters and α-ketoamides |
RU2217436C2 (ru) * | 1996-12-06 | 2003-11-27 | Кортеч, Инк. | Производные оксадиазола, тиадиазола или триазола, являющиеся ингибиторами сериновых протеаз, и содержащие их фармацевтические композиции |
US6656910B2 (en) | 1997-12-04 | 2003-12-02 | Cortech, Inc. | Serine protease inhibitors |
JP2003520185A (ja) | 1998-06-03 | 2003-07-02 | コーテック インコーポレーテッド | セリンプロテアーゼ阻害剤としてのα−ケトオキサジアゾール類 |
US7704958B1 (en) * | 1999-03-05 | 2010-04-27 | Bio Holding, Inc. | Methods and compositions for inhibiting apoptosis using serine protease inhibitors |
WO2003090682A2 (en) * | 2002-04-25 | 2003-11-06 | The Scripps Research Institute | Treatment and prevention of pulmonary conditions |
EP2298278B1 (de) | 2002-06-07 | 2015-11-11 | Dyax Corp. | Verhinderung und Reduzierung von Blutverlust und Entzündungsreaktion |
US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
AU2004268144A1 (en) * | 2003-08-29 | 2005-03-10 | Dyax Corp. | Modified protease inhibitors |
US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
EP1981519B1 (de) * | 2005-12-29 | 2017-12-27 | Dyax Corp. | Proteasehemmung |
CA2696208A1 (en) * | 2007-08-21 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
AU2010203712A1 (en) * | 2009-01-06 | 2010-07-15 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
LT2521568T (lt) | 2010-01-06 | 2018-12-10 | Dyax Corp. | Plazmos kalikreiną surišantys baltymai |
BR112013017080A8 (pt) | 2011-01-06 | 2023-05-09 | Dyax Corp | Anticorpo ou fragmento funcional do mesmo que se liga a forma ativa de calicreína do plasma humano, composiçao farmacêutica e método de detecçao de calicreína do plasma em um paciente |
US10428158B2 (en) | 2014-03-27 | 2019-10-01 | Dyax Corp. | Compositions and methods for treatment of diabetic macular edema |
BR112018011622A2 (pt) | 2015-12-11 | 2018-11-27 | Dyax Corp | método para tratar ataque de angioedema hereditário (hae) ou reduzir a taxa de ataque de hae |
JP2023500182A (ja) | 2019-09-17 | 2023-01-05 | メレオ バイオファーマ 4 リミテッド | 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット |
DK4106757T3 (da) | 2020-04-16 | 2023-10-23 | Mereo Biopharma 4 Ltd | Fremgangsmåder der involverer neutrofil elastase-inhibitor alvelestat til behandling af luftvejssygdom medieret af alpha-1-antitrypsin-mangel |
CA3234399A1 (en) | 2021-10-20 | 2023-04-27 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
US4277395A (en) * | 1980-06-16 | 1981-07-07 | Richardson-Merrell Inc. | Novel enzyme inhibitors |
US4518528A (en) * | 1983-05-19 | 1985-05-21 | Rasnick David W | α Amino fluoro ketones |
DE3324534A1 (de) * | 1983-07-07 | 1985-01-17 | Ciba-Geigy Ag, Basel | Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel |
CA1267499A (en) * | 1983-07-12 | 1990-04-03 | Cedric H. Hassall | Peptide amides and aldehydes |
US4629724A (en) * | 1984-12-03 | 1986-12-16 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitors |
US4643991A (en) * | 1984-12-18 | 1987-02-17 | The University Of Kentucky Research Foundation | Peptide elastase inhibitors and methods |
GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
US5055450A (en) * | 1985-01-22 | 1991-10-08 | Ici Americas Inc. | Peptide derivatives |
US5496927A (en) * | 1985-02-04 | 1996-03-05 | Merrell Pharmaceuticals Inc. | Peptidase inhibitors |
CA1341029C (en) * | 1985-02-04 | 2000-06-20 | Michael Kolb | Peptidase inhibitors |
DE3683541D1 (de) * | 1985-06-07 | 1992-03-05 | Ici America Inc | Selektionierte difluorverbindungen. |
GB8613703D0 (en) * | 1986-06-05 | 1986-07-09 | Ici America Inc | Difluoro peptide compounds |
US4935405A (en) * | 1986-10-31 | 1990-06-19 | Pfizer Inc. | Nor-statine and nor-cyclostatine polypeptides |
US4855303A (en) * | 1987-07-01 | 1989-08-08 | Pfizer Inc. | Fluorine containing renin inhibitors |
EP0318318A1 (de) * | 1987-11-27 | 1989-05-31 | Sensititre Limited | Urintestverfahren und Testsatz |
US5162307A (en) * | 1988-09-09 | 1992-11-10 | Board Of Trustees Of The University Of Kentucky | Polymer bound elastase inhibitors |
EP0371179A1 (de) * | 1988-10-28 | 1990-06-06 | Merrell Dow Pharmaceuticals Inc. | Analoge von Peptidase-Substraten |
EP0369391A3 (de) * | 1988-11-15 | 1991-09-25 | Boehringer Ingelheim Pharmaceuticals Inc. | N-substituierte Amide |
ZA905737B (en) * | 1989-07-26 | 1991-05-29 | Merrell Dow Pharma | Novel peptidase inhibitors |
US5221665A (en) * | 1989-10-27 | 1993-06-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | N-substituted amides |
CA2077665A1 (en) * | 1990-03-05 | 1991-09-06 | Robert Siman | Chymotrypsin-like proteases and their inhibitors |
WO1991015487A1 (fr) * | 1990-03-30 | 1991-10-17 | Japan Tobacco Inc. | Nouveau derive de 4-1-benzoxazine-4h-3,1 |
WO1992012140A1 (en) * | 1990-12-28 | 1992-07-23 | Georgia Tech Research Corporation | Peptides ketoamides, ketoacids, and ketoesters |
US5296591A (en) * | 1990-12-31 | 1994-03-22 | Fujisawa Pharmaceutical Co., Ltd. | Trifluoromethylketone derivatives, processes for preparation thereof and use thereof |
ATE243710T1 (de) * | 1991-03-01 | 2003-07-15 | Dyax Corp | Hemmstoffe für menschliche neutrophile elastase und menschliches kathepsin g |
ATE181925T1 (de) * | 1991-05-23 | 1999-07-15 | Merrell Pharma Inc | Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau |
US5478811A (en) * | 1991-08-22 | 1995-12-26 | Merrell Dow Pharmaceuticals Inc. | Orally-active elastase inhibitors |
AU655831B2 (en) * | 1991-08-22 | 1995-01-12 | Merrell Pharmaceuticals Inc. | Novel orally-active elastase inhibitors |
DK0721449T3 (da) * | 1993-10-01 | 2002-04-22 | Merrell Pharma Inc | Inhibitorer af beta-amyloidproteinproduktion |
JP3721538B2 (ja) * | 1994-06-02 | 2005-11-30 | メレル ファーマスーティカルズ インコーポレイテッド | エラスターゼのパーフルオロアルキルケトン阻害剤およびそれらを製造する方法 |
HU221310B1 (en) * | 1994-06-02 | 2002-09-28 | Merrell Pharma Inc | Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof |
SI0804465T1 (en) * | 1994-06-02 | 2003-12-31 | Aventis Pharmaceuticals Inc. | Novel elastase inhibitors |
-
1995
- 1995-05-01 JP JP50086096A patent/JP3721538B2/ja not_active Expired - Lifetime
- 1995-05-01 WO PCT/US1995/005363 patent/WO1995033762A1/en active IP Right Grant
- 1995-05-01 CA CA002189526A patent/CA2189526C/en not_active Expired - Lifetime
- 1995-05-01 HU HU9603311A patent/HU221311B1/hu not_active IP Right Cessation
- 1995-05-01 ES ES95917216T patent/ES2137509T3/es not_active Expired - Lifetime
- 1995-05-01 DK DK95917216T patent/DK0763055T3/da active
- 1995-05-01 CN CNB951933760A patent/CN1152048C/zh not_active Expired - Fee Related
- 1995-05-01 AT AT95917216T patent/ATE186305T1/de not_active IP Right Cessation
- 1995-05-01 DE DE69513167T patent/DE69513167T2/de not_active Expired - Lifetime
- 1995-05-01 KR KR1019960706819A patent/KR100366328B1/ko not_active IP Right Cessation
- 1995-05-01 AU AU24000/95A patent/AU690986B2/en not_active Ceased
- 1995-05-01 US US08/737,905 patent/US6008196A/en not_active Expired - Lifetime
- 1995-05-01 NZ NZ284766A patent/NZ284766A/en unknown
- 1995-05-01 EP EP95917216A patent/EP0763055B1/de not_active Expired - Lifetime
- 1995-05-31 IL IL11394195A patent/IL113941A/xx not_active IP Right Cessation
- 1995-06-01 TW TW084105552A patent/TW376388B/zh active
-
1996
- 1996-11-29 NO NO19965098A patent/NO316706B1/no unknown
- 1996-11-29 FI FI964789A patent/FI964789A0/fi not_active IP Right Cessation
-
1999
- 1999-12-30 GR GR990403382T patent/GR3032294T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69513167D1 (de) | 1999-12-09 |
HU9603311D0 (en) | 1997-01-28 |
HU221311B1 (en) | 2002-09-28 |
US6008196A (en) | 1999-12-28 |
JPH10501529A (ja) | 1998-02-10 |
CA2189526C (en) | 2001-02-27 |
GR3032294T3 (en) | 2000-04-27 |
IL113941A (en) | 2000-02-17 |
FI964789A (fi) | 1996-11-29 |
EP0763055B1 (de) | 1999-11-03 |
ES2137509T3 (es) | 1999-12-16 |
NO316706B1 (no) | 2004-04-13 |
NZ284766A (en) | 1998-06-26 |
EP0763055A1 (de) | 1997-03-19 |
NO965098D0 (no) | 1996-11-29 |
DE69513167T2 (de) | 2000-06-15 |
AU690986B2 (en) | 1998-05-07 |
HUT75318A (en) | 1997-05-28 |
DK0763055T3 (da) | 2000-05-08 |
KR100366328B1 (ko) | 2003-03-06 |
JP3721538B2 (ja) | 2005-11-30 |
WO1995033762A1 (en) | 1995-12-14 |
CA2189526A1 (en) | 1995-12-14 |
IL113941A0 (en) | 1995-08-31 |
MX9606031A (es) | 1998-05-31 |
CN1149876A (zh) | 1997-05-14 |
FI964789A0 (fi) | 1996-11-29 |
CN1152048C (zh) | 2004-06-02 |
AU2400095A (en) | 1996-01-04 |
TW376388B (en) | 1999-12-11 |
NO965098L (no) | 1997-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE186305T1 (de) | Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
DE69532804D1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
ES2168006T3 (es) | Factor neurotrofico ciliar modificado, metodo de fabricacion y metodos de utilizacion. | |
DE69428791D1 (de) | Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden | |
DE60233265D1 (de) | 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten | |
DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
DE69924375D1 (de) | Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms | |
ATE116848T1 (de) | Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris. | |
ATE307203T1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
ATE390130T1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
DE59900222D1 (de) | Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen | |
HUP0001644A2 (hu) | Eljárás kitinázok előállítására | |
DE69232911D1 (de) | Verwendung eines polyhydroxybenzamids oder dessen Derivat zur Herstellung eines Medikaments für die Behandlung von viralen Infektionen | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
DE69622889D1 (de) | Substituierte 4-(1h-benzimidazol-2-yl)(1,4)diazepane für die behandlung von allergischen krankheiten | |
DE50100833D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
DE69003960D1 (de) | Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten. | |
ATE534399T1 (de) | Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen | |
ES2166800T3 (es) | Procedimiento para la preparacion de o,s-acetales de 2,2-difluoroceteno sililo y o,s-esteres del acido alfa,alfa-difluoro-beta-sililoxi-1,3-dioxolan-4-propanoico. | |
ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
ATE263565T1 (de) | Verwendung von 8,9-dehydroestron zur herstellung eines arzneimittels zur behandlung von durch freie radikale verursachte krankheiten | |
ATE215368T1 (de) | Verwendung von forskolin oder diese enthaltende extrakte zur herstellung eines medikaments für die behandlung von alkoholsucht | |
DE69609541T2 (de) | Verwendung von 6,7-substituierten-2-Aminotetraline zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von septischem Schock, und antipyretischer und antientzündlicher Zusammensetzungen | |
DE59808160D1 (de) | Zusammensetzung zur behandlung von gegerbtem leder, sowie ihre herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |